Related references
Note: Only part of the references are listed.Phase 1 Study of the E-Selectin Inhibitor GMI 1070 in Patients with Sickle Cell Anemia
Ted Wun et al.
PLOS ONE (2014)
A signature of epithelial-mesenchymal plasticity and stromal activation in primary tumor modulates late recurrence in breast cancer independent of disease subtype
Qing Cheng et al.
BREAST CANCER RESEARCH (2014)
Adhesion to osteopontin in the bone marrow niche regulates lymphoblastic leukemia cell dormancy
Benjamin Boyerinas et al.
BLOOD (2013)
Circulating tumor cells and response to neoadjuvant paclitaxel and HER2-targeted therapy: A sub-study from the NeoALTTO phase III trial
Hatem A. Azim et al.
BREAST (2013)
Monitoring apoptosis and Bcl-2 on circulating tumor cells in patients with metastatic breast cancer
Jeffrey B. Smerage et al.
MOLECULAR ONCOLOGY (2013)
Distinct glycosyltransferases synthesize E-selectin ligands in human vs. mouse leukocytes
Nandini Mondal et al.
CELL ADHESION & MIGRATION (2013)
ROCK Inhibitor and Feeder Cells Induce the Conditional Reprogramming of Epithelial Cells
Xuefeng Liu et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
E-Selectin Ligands as Mechanosensitive Receptors on Neutrophils in Health and Disease
S. D. Chase et al.
ANNALS OF BIOMEDICAL ENGINEERING (2012)
The tumor microenvironment modulates tamoxifen resistance in breast cancer: a role for soluble stromal factors and fibronectin through β1 integrin
Osvaldo Pontiggia et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Selectin-deficiency reduces the number of spontaneous metastases in a xenograft model of human breast cancer
Katrin Stuebke et al.
CANCER LETTERS (2012)
Circulating tumour cells in non-metastatic breast cancer: a prospective study
Anthony Lucci et al.
LANCET ONCOLOGY (2012)
Mac-2 Binding Protein Is a Novel E-Selectin Ligand Expressed by Breast Cancer Cells
Venktesh S. Shirure et al.
PLOS ONE (2012)
Dynamics of circulating tumor cells in early breast cancer under neoadjuvant therapy
Maria Jose Serrano et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2012)
Three to Tango: MUC1 as a Ligand for Both E-Selectin and ICAM-1 in the Breast Cancer Metastatic Cascade
Yue Geng et al.
Frontiers in Oncology (2012)
Direct Measurements on CD24-Mediated Rolling of Human Breast Cancer MCF-7 Cells on E-Selectin
Ja Hye Myung et al.
ANALYTICAL CHEMISTRY (2011)
Gangliosides expressed on breast cancer cells are E-selectin ligands
Venktesh S. Shirure et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
Leukocyte ligands for endothelial selectins: specialized glycoconjugates that mediate rolling and signaling under flow
Alexander Zarbock et al.
BLOOD (2011)
Analysis of glycoprotein E-selectin ligands on human and mouse marrow cells enriched for hematopoietic stem/progenitor cells
Jasmeen S. Merzaban et al.
BLOOD (2011)
Potential role of mesenchymal stem cells (MSCs) in the breast tumour microenvironment: stimulation of epithelial to mesenchymal transition (EMT)
F. T. Martin et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Gene set enrichment analysis provides insight into novel signalling pathways in breast cancer stem cells
M. Murohashi et al.
BRITISH JOURNAL OF CANCER (2010)
From carbohydrate leads to glycomimetic drugs
Beat Ernst et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients
Bahriye Aktas et al.
BREAST CANCER RESEARCH (2009)
Inhibition of metastatic outgrowth from single dormant tumor cells by targeting the cytoskeleton
Dalit Barkan et al.
CANCER RESEARCH (2008)
A stromal gene signature associated with inflammatory breast cancer
Brenda J. Boersma et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Maintenance of the hematopoietic stem cell pool by CXCL12-CXCR4 chemokine signaling in bone marrow stromal cell niches
Tatsuki Sugiyama et al.
IMMUNITY (2006)
Cytokines and hematopoietic stem cell mobilization
Bruno Nervi et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2006)
Most early disseminated cancer cells detected in bone marrow of breast cancer patients have a putative breast cancer stem cell phenotype
Marija Balic et al.
CLINICAL CANCER RESEARCH (2006)
Functions of CXCL12 and CXCR4 in breast cancer
Kathryn E. Luker et al.
CANCER LETTERS (2006)
Presence of apoptotic and nonapoptotic disseminated tumor cells reflects the response to neoadjuvant systemic therapy in breast cancer
Tanja Fehm et al.
BREAST CANCER RESEARCH (2006)
The elevated level of CXCR4 is correlated with nodal metastasis of human breast cancer
H Kang et al.
BREAST (2005)
A pooled analysis of bone marrow micrometastasis in breast cancer
S Braun et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Breast cancer metastasis: Markers and models
B Weigelt et al.
NATURE REVIEWS CANCER (2005)
In vivo imaging of specialized bone marrow endothelial microdomains for tumour engraftment
DA Sipkins et al.
NATURE (2005)
Induction of syndecan-1 expression in stromal fibroblasts promotes proliferation of human breast cancer cells
T Maeda et al.
CANCER RESEARCH (2004)
Circulating tumor cells, disease progression, and survival in metastatic breast cancer
M Cristofanilli et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
CXCR4 regulates growth of both primary and metastatic breast cancer
MCP Smith et al.
CANCER RESEARCH (2004)
Prospective identification of tumorigenic breast cancer cells
M Al-Hajj et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Expression pattern of CXC chemokine receptor-4 is correlated with lymph node metastasis in human invasive ductal carcinoma
M Kato et al.
BREAST CANCER RESEARCH (2003)
Chemokine receptor inhibition by AMD3100 is strictly confined to CXCR4
S Hatse et al.
FEBS LETTERS (2002)
G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4
I Petit et al.
NATURE IMMUNOLOGY (2002)
Circulating breast cancer cells are frequently apoptotic
G Méhes et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
Involvement of chemokine receptors in breast cancer metastasis
A Müller et al.
NATURE (2001)
Share Paper
